IUPAC name
[(2R)-2-(acetyloxy)-3-carboxypropyl]trimethylazanium
SMILES
CC(=O)O[C@H](CC(O)=O)C[N+](C)(C)C
Compound class
Therapeutic area
Acetylcarnitine is not approved for any indication in the United states and Canada, but it is approved and indicated in Italy for cerebrovascular disorders, mental function disorders, peripheral nerve disorders, diabetic neuropathy, and nutritional supplementation; Portugal for mental function disorders; Argentina for cerebral vasculopathy, nutritional supplementation, and peripheral neuropathy; Chile for dementia; Philippines for cerebrovascular disorders and mental function disorders; Australia for nutritional supplementation; and India for nutritional supplementation to increase sperm count. Acetylcarnitine also has several potential therapeutic indications for which it is still being investigated: in Norway, acetylcarnitine is in a phase IV trial for prophylactic treatment of migraines; in Italy acetylcarnitine is in a phase II trial for use in patients with type 2 Diabetes Mellitus, a phase III trial for alleviating fatigue in patients with chronic hepatitis C, and for use in patients with Minimal Hepatic Encephalopathy; in the United States acetylcarnitine is in a phase II trial for the neurodegenerative disorder Progressive Supranuclear Palsy, a phase II and III trial for reducing peripheral neuropathy in cancer patients as an adjunct to chemotherapy, a phase I and II trial for treating patients in septic shock, a phase II trial for bipolar depression, a phase II trial to reduce oxidative stress in patients with Sickle Cell disease, a phase I and II trial for chronic fatigue syndrome, and a study for preventing nerve damage in HIV patients; in China acetylcarnitine is in a phase III trial for reducing peripheral neuropathy in cancer patients as an adjunct to chemotherapy; in the United Kingdom acetylcarnitine is being investigated for preventing nerve damage in HIV patients; and in Israel acetylcarnitine is being studied for the treatment of male infertility.
Common name
Acetylcarnitine
IUPAC name
[(2R)-2-(acetyloxy)-3-carboxypropyl]trimethylazanium
SMILES
CC(=O)O[C@H](CC(O)=O)C[N+](C)(C)C
INCHI
InChI=1S/C9H17NO4/c1-7(11)14-8(5-9(12)13)6-10(2,3)4/h8H,5-6H2,1-4H3/p+1/t8-/m1/s1
FORMULA
C9H18NO4
Common name
Acetylcarnitine
IUPAC name
[(2R)-2-(acetyloxy)-3-carboxypropyl]trimethylazanium
Molecular weight
204.244
clogP
-2.632
clogS
-1.411
HBond Acceptor
4
HBond Donor
1
Total Polar Surface Area
63.6
Number of Rings
0
Rotatable Bond
6
